Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: TAMOXIFEN - THERAPEUTIC USE , . Treffer: 19
2015
Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol. 2015; 26(8):1685-1691
Doi: 10.1093/annonc/mdv215
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Gnant, M; Filipits, M; Greil, R; Stoeger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Knauer, M; Singer, C; Jakesz, R; Dubsky, P; Fitzal, F; Bartsch, R; Steger, G; Balic, M; Ressler, S; Cowens, JW; Storhoff, J; Ferree, S; Schaper, C; Liu, S; Fesl, C; Nielsen, TO; Austrian Breast and Colorectal Cancer Study Group
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Ann Oncol. 2014; 25(2):339-345
Doi: 10.1093/annonc/mdt494
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Province, MA; Goetz, MP; Brauch, H; Flockhart, DA; Hebert, JM; Whaley, R; Suman, VJ; Schroth, W; Winter, S; Zembutsu, H; Mushiroda, T; Newman, WG; Lee, MT; Ambrosone, CB; Beckmann, MW; Choi, JY; Dieudonné, AS; Fasching, PA; Ferraldeschi, R; Gong, L; Haschke-Becher, E; Howell, A; Jordan, LB; Hamann, U; Kiyotani, K; Krippl, P; Lambrechts, D; Latif, A; Langsenlehner, U; Lorizio, W; Neven, P; Nguyen, AT; Park, BW; Purdie, CA; Quinlan, P; Renner, W; Schmidt, M; Schwab, M; Shin, JG; Stingl, JC; Wegman, P; Wingren, S; Wu, AH; Ziv, E; Zirpoli, G; Thompson, AM; Jordan, VC; Nakamura, Y; Altman, RB; Ames, MM; Weinshilboum, RM; Eichelbaum, M; Ingle, JN; Klein, TE; International Tamoxifen Pharmacogenomics Consortium
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Clin Pharmacol Ther. 2014; 95(2):216-227
Doi: 10.1038/clpt.2013.186
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Paetzold, S; Gary, T; Hafner, F; Brodmann, M
Thrombosis of the inferior vena cava related to Ormond's disease.
Clin Rheumatol. 2013; 32 Suppl 1(3): S67-S70.
Doi: 10.1007/s10067-010-1456-9
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Pfeiler, G; Stöger, H; Dubsky, P; Mlineritsch, B; Singer, C; Balic, M; Fitzal, F; Moik, M; Kwasny, W; Selim, U; Renner, K; Ploner, F; Steger, GG; Seifert, M; Hofbauer, F; Sandbichler, P; Samonigg, H; Jakesz, R; Greil, R; Fesl, C; Gnant, M; ABCSG
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Br J Cancer. 2013; 108(7):1408-1414
Doi: 10.1038/bjc.2013.114
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Dubsky, PC; Jakesz, R; Mlineritsch, B; Pöstlberger, S; Samonigg, H; Kwasny, W; Tausch, C; Stöger, H; Haider, K; Fitzal, F; Singer, CF; Stierer, M; Sevelda, P; Luschin-Ebengreuth, G; Taucher, S; Rudas, M; Bartsch, R; Steger, GG; Greil, R; Filipcic, L; Gnant, M
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2012; 30(7):722-728
Doi: 10.1200/JCO.2011.36.8993
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Heck, D; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Pristauz, G; Bauernhofer, T; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Hochreiner, G; Forsthuber, EP; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Lancet Oncol. 2011; 12(7):631-641
Doi: 10.1016/S1470-2045(11)70122-X
Web of Science
PubMed
FullText
FullText_MUG
2010
Symmans, WF; Hatzis, C; Sotiriou, C; Andre, F; Peintinger, F; Regitnig, P; Daxenbichler, G; Desmedt, C; Domont, J; Marth, C; Delaloge, S; Bauernhofer, T; Valero, V; Booser, DJ; Hortobagyi, GN; Pusztai, L
Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer.
J Clin Oncol. 2010; 28(27): 4111-4119.
Doi: 10.1200/JCO.2010.28.4273
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2009
Filipits, M; Rudas, M; Heinzl, H; Jakesz, R; Kubista, E; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Nader, A; Stierer, M; Gnant, MF; Austrian Breast and Colorectal Cancer Study Group
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Clin Cancer Res. 2009; 15(18):5888-5894
Doi: 10.1158/1078-0432.CCR-09-0728
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Pöstlberger, S; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Bjelic-Radisic, V; Samonigg, H; Tausch, C; Eidtmann, H; Steger, G; Kwasny, W; Dubsky, P; Fridrik, M; Fitzal, F; Stierer, M; Rücklinger, E; Greil, R; ABCSG-12 Trial Investigators; Marth, C
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med. 2009; 360(7):679-691
Doi: 10.1056/NEJMoa0806285
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2008
Rudas, M; Lehnert, M; Huynh, A; Jakesz, R; Singer, C; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Grill, R; Stierer, M; Gnant, MF; Filipits, M; Austrian Breast and Colorectal Cancer Study Group
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
CLIN CANCER RES. 2008; 14(6): 1767-1774.
Doi: 10.1158/1078-0432.CCR-07-4122
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
Jakesz, R; Greil, R; Gnant, M; Schmid, M; Kwasny, W; Kubista, E; Mineritsch, B; Tausch, C; Stierer, M; Hofbauer, F; Renner, K; Dadak, C; Ruecklinger, E; Samonigg, H
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
J Natl Cancer Inst. 2007; 99(24):1845-1853
Doi: 10.1093/jnci/djm246
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pötter, R; Gnant, M; Kwasny, W; Tausch, C; Handl-Zeller, L; Pakisch, B; Taucher, S; Hammer, J; Luschin-Ebengreuth, G; Schmid, M; Sedlmayer, F; Stierer, M; Reiner, G; Kapp, K; Hofbauer, F; Rottenfusser, A; Pöstlberger, S; Haider, K; Draxler, W; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group
Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
INT J RADIAT ONCOL BIOL PHYS. 2007; 68(2): 334-340.
Doi: 10.1016/j.ijrobp.2006.12.045
Web of Science
PubMed
FullText
FullText_MUG
2005
Filipits, M; Pohl, G; Rudas, M; Dietze, O; Lax, S; Grill, R; Pirker, R; Zielinski, CC; Hausmaninger, H; Kubista, E; Samonigg, H; Jakesz, R
Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2005; 23(6):1161-1168
Doi: 10.1200/JCO.2005.03.033
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Reich, O; Regauer, S
Is tamoxifen an option for patients with endometrial stromal sarcoma?
Gynecol Oncol. 2005; 96(2):561; author reply 561-561; author reply 561
Doi: 10.1016/j.ygyno.2004.11.003
Web of Science
PubMed
FullText
FullText_MUG
2003
Pohl, G; Rudas, M; Dietze, O; Lax, S; Markis, E; Pirker, R; Zielinski, CC; Hausmaninger, H; Kubista, E; Samonigg, H; Jakesz, R; Filipits, M
High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.
J Clin Oncol. 2003; 21(19):3594-3600
Doi: 10.1200/JCO.2003.02.021
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1999
Jakesz, R; Hausmaninger, H; Haider, K; Kubista, E; Samonigg, H; Gnant, M; Manfreda, D; Tschurtschenthaler, G; Kolb, R; Stierer, M; Fridrik, M; Mlineritsch, B; Steindorfer, P; Mittlböck, M; Steger, G
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
J Clin Oncol. 1999; 17(6):1701-1709
Doi: 10.1200/JCO.1999.17.6.1701
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Kucera, E; Speiser, P; Gnant, M; Szabo, L; Samonigg, H; Hausmaninger, H; Mittlböck, M; Fridrik, M; Seifert, M; Kubista, E; Reiner, A; Zeillinger, R; Jakesz, R
Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Austrian Breast Cancer Study Group.
Eur J Cancer. 1999; 35(3):398-405
Doi: 10.1016/S0959-8049(98)00400-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1997
Lackner, H; Urban, C; Kerbl, R; Schwinger, W; Beham, A
Noncytotoxic drug therapy in children with unresectable desmoid tumors.
Cancer. 1997; 80(2):334-340
Doi: 10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C334%3A%3AAID-CNCR22%3E3.0.CO%3B2-U
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar